These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17283171)

  • 21. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo single-cell dosimetry of I-131, I-125 and I-123 for targeted radioimmunotherapy of B-cell lymphoma.
    Bousis C; Emfietzoglou D; Nikjoo H
    Int J Radiat Biol; 2012 Dec; 88(12):908-15. PubMed ID: 22348681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
    Kotzerke J; Glatting G; Seitz U; Rentschler M; Neumaier B; Bunjes D; Duncker C; Dohr D; Bergmann L; Reske SN
    J Nucl Med; 2000 Mar; 41(3):531-7. PubMed ID: 10716329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
    Knogler K; Grünberg J; Zimmermann K; Cohrs S; Honer M; Ametamey S; Altevogt P; Fogel M; Schubiger PA; Novak-Hofer I
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):603-11. PubMed ID: 17255283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma.
    Illidge TM; Cragg MS; McBride HM; French RR; Glennie MJ
    Blood; 1999 Jul; 94(1):233-43. PubMed ID: 10381518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
    DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
    Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
    Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Michel RB; Andrews PM; Rosario AV; Goldenberg DM; Mattes MJ
    Nucl Med Biol; 2005 Apr; 32(3):269-78. PubMed ID: 15820762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
    Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
    Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen.
    Al-Ejeh F; Darby JM; Pensa K; Diener KR; Hayball JD; Brown MP
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5519s-5527s. PubMed ID: 17875784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
    Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
    Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.
    Honeychurch J; Glennie MJ; Illidge TM
    Cancer Res; 2005 Aug; 65(16):7493-501. PubMed ID: 16103104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab).
    Mattes MJ; Sharkey RM; Karacay H; Czuczman MS; Goldenberg DM
    Clin Cancer Res; 2008 Oct; 14(19):6154-60. PubMed ID: 18829494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
    Kraeber-Bodéré F; Faivre-Chauvet A; Ferrer L; Vuillez JP; Brard PY; Rousseau C; Resche I; Devillers A; Laffont S; Bardiès M; Chang K; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3973S-81S. PubMed ID: 14506196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas.
    El Emir E; Qureshi U; Dearling JL; Boxer GM; Clatworthy I; Folarin AA; Robson MP; Nagl S; Konerding MA; Pedley RB
    Cancer Res; 2007 Dec; 67(24):11896-905. PubMed ID: 18089820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
    Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
    J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.